Elevai Labs Inc (NASDAQ: ELAB)’s stock price has decreased by -2.48 compared to its previous closing price of 0.02. However, the company has seen a -10.86% decrease in its stock price over the last five trading sessions. globenewswire.com reported 2024-11-14 that NEWPORT BEACH, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) — In a release earlier today by Elevai Labs Inc. (NASDAQ: ELAB), please note that in the headline and first paragraph, the financial results are from the company’s third fiscal quarter of 2024, not the second fiscal quarter as previously stated; as such, the header over the first bullet list should note the financial results as being from the three and nine months ended September 30, 2024, rather than the three and six months ended June 30, 2024 as previous stated.
Is It Worth Investing in Elevai Labs Inc (NASDAQ: ELAB) Right Now?
Additionally, the 36-month beta value for ELAB is -0.84.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ELAB is 39.35M and currently, short sellers hold a 23.95% ratio of that float. The average trading volume of ELAB on November 22, 2024 was 116.75M shares.
ELAB’s Market Performance
ELAB stock saw a decrease of -10.86% in the past week, with a monthly decline of -78.63% and a quarterly a decrease of -93.84%. The volatility ratio for the week is 15.22%, and the volatility levels for the last 30 days are 26.11% for Elevai Labs Inc (ELAB). The simple moving average for the last 20 days is -43.10% for ELAB stock, with a simple moving average of -95.64% for the last 200 days.
ELAB Trading at -78.74% from the 50-Day Moving Average
After a stumble in the market that brought ELAB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.54% of loss for the given period.
Volatility was left at 26.11%, however, over the last 30 days, the volatility rate increased by 15.22%, as shares sank -80.75% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -94.43% lower at present.
During the last 5 trading sessions, ELAB fell by -11.76%, which changed the moving average for the period of 200-days by -96.95% in comparison to the 20-day moving average, which settled at $0.0346. In addition, Elevai Labs Inc saw -98.92% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ELAB
Current profitability levels for the company are sitting at:
- -1.7 for the present operating margin
- 0.7 for the gross margin
The net margin for Elevai Labs Inc stands at -2.24. The total capital return value is set at -0.46. Equity return is now at value -130.35, with -85.53 for asset returns.
Currently, EBITDA for the company is -4.27 million with net debt to EBITDA at 1.37. When we switch over and look at the enterprise to sales, we see a ratio of 1.8. The receivables turnover for the company is 87.72for trailing twelve months and the total asset turnover is 0.22. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.86.
Conclusion
In conclusion, Elevai Labs Inc (ELAB) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
